Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a funding note indicating a 2018 U.S. NIH grant/contract. Added a forthcoming publication citation for Pfister R et al., 'ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis' in Cardiol Ther, 2026 Aug 20.
    Difference
    0.1%
    Check dated 2026-08-25T20:20:22.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    An additional publication citation with a long author list and the plain-language summary of acoramidis was added to the Publications section. A new revision tag (Revision: v3.6.5) was introduced and the previous tag (Revision: v3.6.4) removed, reflecting an update to the study's documentation.
    Difference
    0.1%
    Check dated 2026-08-11T18:36:34.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a new publication citation to the Publications section for a 2026 JAMA Cardiology study that analyzes acoramidis (AG10) effects on heart failure-related health status in ATTR-CM. This external analysis expands the evidentiary context of the trial’s investigational drug.
    Difference
    0.0%
    Check dated 2026-08-04T15:50:43.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.3 to v3.6.4, indicating a new version of the page or its underlying template. This appears to be an administrative update with no impact on study details, eligibility criteria, or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-21T12:56:46.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new publication citation by Testani JM et al. is added to Publications, describing the effects of acoramidis on kidney function in transthyretin amyloid cardiomyopathy (Circ Heart Fail. 2026). This entry updates the study record with recent related literature.
    Difference
    0.0%
    Check dated 2026-07-07T06:38:25.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.0 to v3.6.3, reflecting a new version of the page template or documentation, while the study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-30T02:20:26.000Z thumbnail image

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.